logo

FABTECH vs SAKAR: Stock Comparison

FABTECH TECHNOLOGIES vs SAKAR HEALTHCAREUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

SAKAR HEALTHCARE is the larger company by market capitalisation. FABTECH TECHNOLOGIES shows a lower P/E, a higher dividend yield and lower leverage, while SAKAR HEALTHCARE shows a higher ROE, faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FABTECH leads 5; SAKAR leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FABTECHSAKAR

Valuation lens

What price are you paying?

Market CapContext only
₹579 Cr
₹2,047 Cr
P/E RatioFABTECH has the lower reading
11.89x ✓
56.71x
P/B RatioFABTECH has the lower reading
1.38x ✓
6.31x
EPSSAKAR has the higher reading
₹0.95
₹4.62 ✓
Book ValueContext only
₹94.43
₹128.3
Dividend YieldFABTECH has the higher reading
0.46% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SAKAR is the larger company
₹2,047 Cr vs ₹579 Cr
P/E Ratio
FABTECH has a lower P/E
11.89x vs 56.71x
P/B Ratio
FABTECH has a lower P/B
1.38x vs 6.31x
EPS
SAKAR has higher earnings per share
₹4.62 vs ₹0.95
Dividend Yield
FABTECH has a higher dividend yield
0.46% vs 0%
Revenue Growth (TTM YoY)
SAKAR has faster revenue growth
40.1% vs 17.5%
EPS Growth (TTM YoY)
SAKAR has faster EPS growth
87.2% vs 23.4%
ROE
SAKAR has a higher ROE
10.68% vs 9.14%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFABTECHSAKAR
SectorHealthcareHealthcare
IndustryMedical Equipment & SuppliesPharmaceuticals

Price

MetricFABTECHSAKAR
Live Price₹131.39₹923.2
Day Change0.84%-4%
Volume60,38966,081
52-Week High₹262.8₹1,229.85
52-Week Low₹128.94₹350.1
Distance from 52W High-50%-24.93%

Valuation

MetricFABTECHSAKAR
Market Cap₹579 Cr₹2,047 Cr
P/E Ratio11.89x56.71x
P/B Ratio1.38x6.31x
EPS₹0.95₹4.62
Book Value₹94.43₹128.3
Dividend Yield0.46%0%

Growth

MetricFABTECHSAKAR
Revenue Growth (TTM YoY)17.5%40.1%
EPS Growth (TTM YoY)23.4%87.2%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricFABTECHSAKAR
ROE9.14%10.68%
ROCE10.2%10.13%
Net Margin11.28%12.11%
Operating Margin12.67%18.91%
Debt to Equity0.1x0.26x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricFABTECHSAKAR
Promoter Holding69.03%▲ 0.09 pp51.7%▼ 0.82 pp
FII Holding0.02%12.34%▲ 0.21 pp
DII Holding2.45%11.92%▲ 0.55 pp
Public Holding28.49%▼ 0.09 pp24.04%▲ 0.06 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FABTECH TECHNOLOGIES and SAKAR HEALTHCARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.